Viswanath Gunda

机构：Stanford University

发表论文 58 篇 · 总被引 2865 次 · h-index 22

代表论文

• CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation (2017 · Cancer Discovery · 被引 801)
• Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids (2017 · Cancer Discovery · 被引 605)
• Anti‐PD‐1/PD‐L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer (2018 · International Journal of Cancer · 被引 114)
• Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer (2018 · British Journal of Cancer · 被引 111)
• Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer (2016 · Oncotarget · 被引 107)
• Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer (2016 · Proceedings of the National Academy of Sciences · 被引 91)